[1]
“ROLE OF GLP-1 AGONISTS IN THE TREATMENT OF OBESITY-RELATED GASTROINTESTINAL DISORDERS”, RMSR, vol. 3, no. 4, pp. 1205–1214, Apr. 2025, Accessed: Oct. 12, 2026. [Online]. Available: https://medicalsciencereview.com/index.php/Journal/article/view/1966